Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Fri, 08/27/10 - 11:10 am
Tags:
Arena Pharmaceuticals, obesity, FDA, Vivus, Orexigen, Contrave, Qnexa
When the Disease Matters Most in Drug Approval
Motley Fool
Wed, 08/11/10 - 11:08 am
Tags:
drug development, JNJ, Vivus, Valeant Pharmaceuticals, GSK, Pfizer, Abbott Laboratories
Arena's Obesity Drug Likely to Pass FDA Panel With Flying Colors
Seeking Alpha
Mon, 08/9/10 - 09:46 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Orexigen, Contrave, Qnexa, FDA
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Tags:
Vivus, downgrades, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Orexigen Steps Up Pace in Obesity Drug Race
Seeking Alpha
Sun, 08/1/10 - 02:47 pm
Tags:
Orexigen, Arena Pharmaceuticals, Vivus, Contrave, Qnexa
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Fri, 07/30/10 - 11:05 am
Tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals
Vivus's Obesity Drug Raises Familiar Questions
Seeking Alpha
Mon, 07/26/10 - 11:16 am
Tags:
Vivus, obesity, Arena Pharmaceuticals, Contrave, Orexigen, Qnexa
The Value of an SPA for Avanir Pharmaceuticals
Seeking Alpha
Fri, 07/23/10 - 06:38 am
Tags:
Vivus, SPA, Avanir
Biotech Stock Mailbag: Ziopharm
TheStreet.com
Thu, 07/22/10 - 09:29 am
Tags:
Ziopharm, MELA Sciences, Vivus
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wed, 07/21/10 - 03:55 pm
Tags:
obesity, Vivus, Qnexa, FDA, Arena Pharmaceuticals, Contrave, Orexigen
Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes
Seeking Alpha
Mon, 07/19/10 - 09:13 am
Tags:
GSK, Vivus, Eli Lilly, Biogen Idec, Novartis, Sanofi, Vernalis
Lessons Learned About the Outlook for New Obesity Drug Approval
Motley Fool
Sun, 07/18/10 - 07:43 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Qnexa, Contrave, Orexigen
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Fri, 07/16/10 - 10:05 am
Tags:
Vivus, Arena Pharmaceuticals, FDA, Orexigen, Contrave, Qnexa
Vivus: What Happens Next?
TheStreet.com
Fri, 07/16/10 - 08:21 am
Tags:
Vivus, Qnexa, obesity, Contrave, Arena Pharmaceuticals, Orexigen, FDA
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
WSJ Online
Thu, 07/15/10 - 06:04 pm
Tags:
FDA, obesity, Vivus, Qnexa, advisory panels, Orexigen, Arena Pharmaceuticals, Contrave
Arena rallies on FDA optimism; Vivus shares halted
Marketwatch
Thu, 07/15/10 - 11:17 am
Tags:
FDA, advisory panels, Qnexa, Arena Pharmaceuticals, Vivus
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Yahoo/AP
Thu, 07/15/10 - 10:19 am
Tags:
obesity, Arena Pharmaceuticals, Qnexa, Contrave, Orexigen, Vivus
Live Blog--Vivus' FDA Advisory Panel
TheStreet.com
Thu, 07/15/10 - 09:05 am
Tags:
Vivus, Orexigen, obesity, FDA, Arena Pharmaceuticals, advisory panels, Qnexa
Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling
Seeking Alpha
Wed, 07/14/10 - 10:35 am
Tags:
obesity, Qnexa, FDA, Vivus, Contrave, Orexigen, Arena Pharmaceuticals
Vivus's Implied Volatility Gets Extreme
Seeking Alpha
Tue, 07/13/10 - 09:16 pm
Tags:
Vivus, Qnexa, obesity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.